Skip to main content

Advertisement

SpringerLink
Log in

Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Clinical characteristics of antitumor necrosis factor (TNF) agents-related tuberculosis (TB) in ankylosing spondylitis (AS) are not well described. The aim was to compare the incidences and the characteristics of TB in AS and rheumatoid arthritis (RA) during TNF inhibitor treatment. AS (n = 1,322) and RA (n = 3,154) patients who received medical care between January 2001 and August 2011 were enrolled. The incidence of TB in patients treated, or not, with TNF inhibitors and the clinical features associated with TB were explored. Seven patients with AS and seven with RA developed TB while receiving TNF inhibitor therapy, resulting in an incidence rate of 600.2/100,000 person-years (PYs) (95 % confidence interval (CI), 241.3–1236.3) for those with AS and 771.6/100,000 PYs (95 % CI, 310.2–1589.9) for those with RA. Incidence rate ratios for TNF inhibitor-treated vs. untreated patients were 4.87 for AS (95 % CI, 1.50–15.39; p < 0.001) and 3.61 for RA (95 % CI, 1.38–8.07; p < 0.001). Low body mass index was identified as a significant risk factor for TB in the AS group (odds ratio (OR), 13.0; p = 0.002). Extrapulmonary TB was predominant at 85.7 % during TNF inhibitor treatment. Three (42.8 %) of the AS patients, but none of the RA patients, developed TB with concomitant isoniazid. All AS patients recovered from TB whereas two of seven RA patients died. Treatment with TNF inhibitors significantly increases the risk of extrapulmonary TB in AS. Symptoms of infection should warrant clinicians to evaluate for TB during TNF inhibitor therapy in AS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  CAS  PubMed  Google Scholar 

  2. Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T (2011) Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 78:279–284

    Article  PubMed  Google Scholar 

  3. Braun J, Sieper J (2002) Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches. Arthritis Res 4:307–321

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Davis JC, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO et al (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48:3230–3236

    Article  CAS  PubMed  Google Scholar 

  5. Dixon W, Hyrich K, Watson K, Lunt M, Galloway J, Ustianowski A et al (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69:522–528

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D et al (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372:375–382

    Article  CAS  PubMed  Google Scholar 

  7. Feldmann M (2002) Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2:364–371

    CAS  PubMed  Google Scholar 

  8. Fiske CT, de Almeida AS, Shintani AK, Kalams SA, Sterling TR (2012) Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis. Clin Vaccine Immunol 19:1142–1149

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP et al (2011) Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50:124–131

    Article  CAS  Google Scholar 

  10. Gómez–Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active–surveillance report. Arthritis Rheum 48:2122–2127

    Article  PubMed  Google Scholar 

  11. Hou CL, Tsai YC, Chen LC, Huang JL (2008) Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol 27:557–563

    Article  PubMed  Google Scholar 

  12. Jacobs M, Samarina A, Grivennikov S, Botha T, Allie N, Fremond C et al (2007) Review: reactivation of tuberculosis by tumor necrosis factor neutralization. Eur Cytokine Network 18:1–9

    Google Scholar 

  13. Keane J (2004) Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 39:300–302

    Article  CAS  PubMed  Google Scholar 

  14. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345:1098–1104

    Article  CAS  PubMed  Google Scholar 

  15. Kim EM, Uhm WS, Bae SC, Yoo DH, Kim TH (2011) Incidence of tuberculosis among Korean patients with ankylosing spondylitis who are taking tumor necrosis factor blockers. J Rheumatol 38:2218–2223

    Article  PubMed  Google Scholar 

  16. Lee H, Dockrell HM, Kim DR, Floyd S, Oh SY, Lee JB et al (2012) The current status of BCG vaccination in young children in South Korea. Tuberc Respir Dis 72:374–380

    Article  Google Scholar 

  17. Lee SK, Kim SY, Kim EY, Jung JY, Park MS, Kim YS et al. (2013) Mycobacterial Infections in patients treated with tumor necrosis factor antagonists in South Korea. Lung (in press)

  18. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G et al (2007) Lower risk of tuberculosis in obesity. Arch Intern Med 167:1297

    Article  PubMed  Google Scholar 

  19. Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E (2002) Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 31:44–45

    Article  PubMed  Google Scholar 

  20. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219

    Article  CAS  PubMed  Google Scholar 

  21. Park JS (2012) Korean guidelines for the treatment of tuberculosis. Korean J Med 82:269–273

    Article  Google Scholar 

  22. Querini PR, Vecellio M, Sabbadini M, Ciboddo G (2002) Miliary tuberculosis after biological therapy for rheumatoid arthritis. Rheumatology 41:231

    Article  Google Scholar 

  23. St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50:3432–3443

    Article  CAS  PubMed  Google Scholar 

  24. Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399–405

    Article  PubMed  Google Scholar 

  25. van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P et al (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo–controlled trial (ASSERT). Arthritis Rheum 52:582–591

    Article  PubMed  Google Scholar 

  26. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  27. Wallis R, Broder M, Wong J, Hanson M, Beenhouwer D (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261–1265

    Article  CAS  PubMed  Google Scholar 

  28. Weir MR, Thornton GF (1985) Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med 79:467–478

    Article  CAS  PubMed  Google Scholar 

  29. Westhovens R, Yocum D, Han J, Berman A, Strusberg I, Geusens P et al (2006) The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo–controlled trial. Arthritis Rheum 54:1075–1086

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Eulji University School of Medicine, Eulji General Hospital, Seoul, South Korea

    Hye Won Kim

  2. Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

    Jin Kyun Park, Ji-Ae Yang, Young Im Yoon, Eun Young Lee, Yeong Wook Song & Eun Bong Lee

  3. Department of Anatomy, Seoul National University College of Medicine, Seoul, South Korea

    Hang Rae Kim

Authors
  1. Hye Won Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Kyun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ji-Ae Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Young Im Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eun Young Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yeong Wook Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hang Rae Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eun Bong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eun Bong Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, H.W., Park, J.K., Yang, JA. et al. Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area. Clin Rheumatol 33, 1307–1312 (2014). https://doi.org/10.1007/s10067-013-2387-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-013-2387-z

Keywords

Search

Navigation